Thomas Ross
In order to view Thomas Ross's profile, please login
Login
ABOUT

You must be logged in to see Thomas Ross's about summary.

Biomune Inc. has developed a plant based immunotherapy using the mitogens from two common weeds. Our pre-clinical data had 95% cure rate on three cancers, with best application being oral. We plan to market a neutraceutical version without claims other than immune stimulation. Then develop the pharmaceutical version.

Contact & Other Info

You must be logged in to see Thomas Ross's contact details.

Education

You must be logged in to see Thomas Ross's education details.

Experience

You must be logged in to see Thomas Ross's work experience details.